header_left.jpg header_right.jpg
CPOB > Publications

CPOB Publications

The following is a list of publications produced by CPOB staff and study colleagues.

CATT Study Publications

The CATT Research Group.  Ranibizumab and bevacizumab for neovascular age-related macular degeneration.  N Engl J Med 2011; 364:1897-908. Epub 2011 Apr 28.  PMC3157322.

The CATT Research Group. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: 2-year results.  Ophthalmology 2012; 119:1388–1398. Epub 2012 May 1.  PMC3389193.

Grunwald JE, Daniel E, Ying G-S, Pistilli M, Maguire MG, Alexander J, Whittock-Martin R, Parker CR, Sepielli K, Blodi BA, Martin DF, the CATT Research Group.  Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials.  Ophthalmology 2012.  Epub 2012 Apr 17.  PMC3401277.

DeCroos FC, Toth CA, Stinnett SS, Heydary CS, Burns R, Jaffe GJ, for the CATT Research Group.  Optical coherence tomography grading reproducibility during the Comparison of Age-Related Macular Degeneration Treatments Trials.  Ophthalmology 2012; 119:2549-57.  Epub 2012 Aug 28.  PMC3631582.

Ying G-S, Huang J. Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF, the CATT Research Group.  Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.  Ophthalmology 2013; 120:122-129.  Epub 2012 Oct 6.  PMC3536921.

Hagstrom SA, Ying G-S, Pauer GJT, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF, the Comparison of AMD Treatments Trials Research Group.  Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).  Ophthalmology 2013; 120:593-9.  Epub 2013 Jan 18.  PMC 3633658.

Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying G-S, Grunwald JE, Huang J, the CATT Research Group.  Macular morphology and visual acuity in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).  Ophthalmology 2013; 120:1860-70. Epub 2013 May 03. PMC3737287.

Maguire MG, Daniel E, Shah AR, Grunwald JE, Hagstrom SA, Avery RL, Huang J, Martin RW, Roth DB, Castellarin AA, Bakri SJ, Fine SL, Martin DF, the CATT Research Group. Incidence of choroidal neovascularization in the fellow eye in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2013; 120:2033-41. Epub 2013 May 23. PMC3758381.

Grunwald JE, Daniel E, Huang J, Ying G-S, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, the CATT Research Group. Risk of geographic atrophy in Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2014; 121:150-161. Epub 2013 Sep 30. PMC3892560.

Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, Ying G-S, Huang J, Winter K, Hagstrom SA, Maguire MG, the  CATT Research Group. Risk of scar in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).  Ophthalmology 2014; 121:656-66. Epub 2013 Dec 4.  PMC3943618.

Hagstrom SA, Ying G-S, Pauer GJT, Sturgill-Short GM, Huang J, Maguire MG, Martin DF.  VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy in the Comparison of AMD Treatments Trials (CATT).  JAMA Ophthalmology 2014; 132:521-7.  Epub 2014 Mar 20.

Kim BJ, Ying GS, Huang J, Levy N, Maguire MG, and the CATT Research Group.  Sporadic visual acuity loss in the Comparison of AMD Treatments Trials (CATT). Am J Ophthalmol 2014; 158:128-135. Epub 2014 Apr 10.

Folgar FA, Jaffe GJ, Ying G-S, Maguire MG, Toth CA, the CATT Research Group. Comparison of optical coherence tomography assessments in in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2014;121:1956-1965.  Epub 2014 May 15.

Ying G-S, Kim BJ, Maguire MG, Huang J, Daniel E, Jaffe GJ, Grunwald JE,  Blinder KJ, Flaxel CJ, Rahhal R, Regillo C, Martin DF, the CATT Research Group.  Sustained Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT).  JAMA Ophthalmology 2014;132:915-921.  Epub 2014 May 29.

Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, and the CATT Research Group. Delayed Patchy Choroidal Filling in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol.  Epub 2014 Jun 17.

Lee JY, Folgar FA, Maguire MG, Ying GS, Toth CA, Martin DF, Jaffe GJ, the CATT Research Group. Outer Retinal Tubulation in the Comparison of Age-related Macular Degneration Treatments Trials (CATT).  Ophthalmology. Epub 2014 July 23.

Moja L, Lucenteforte E, Kwag K, Bertele V, Campomori A, Chakravarthy U, Dickersin K, Evans J, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Reeves BC, Rogers CA, Schmucker C, Subramanian ML, D’Amico R, Virgili G. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane Database Syst Rev. 2014 Sep 15;9:CD011230. [Collaborative Paper]

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL, Fine SL, Maguire MG, the CATT Research Group.  Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).  Ophthalmology.  Epub 2014 Oct 09.

 CATT Editorials and Commentary

Martin DF, Maguire MG, Fine SL. Identifying and eliminating the roadblocks to comparative-effectiveness research. N Engl J Med 2010; 363:105-7.  Epub 2010 Jun 2.

Martin DF, Maguire MG, Fine SL.  Bevacizumab: not as good with more adverse reactions? Response. Clinical and Experimental Ophthalmology 2011; 39:718-720.

Martin DF, Maguire MG, Fine SL.  Ranibizumab and bevacizumab for AMD.  Authors reply. N Engl J Med 2011; 365:2237.

Grunwald JE.  Risk of geographic atrophy in Comparison of Age-related Macular Degeneration Treatments Trials.  Authors reply. Ophthalmology. Epub 2014 Mar 7.

Hagstrom S, Ying G-S, Maguire MG, Martin D. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).  Authors reply. Ophthalmology 2014; 121:e44-5. Epub 2014 May 6.

Martin DF, Fine SL, Maguire MG. Cost-Related Motivations for Research.  Letter to the Editor. JAMA 2014; 312:847.

Hagstrom S, Ying GS, Pauer GJ, Huang J, Maguire MG, Martin DF. Endothelial PAS domain-containing protein 1 (EPAS1) gene polymorphisms and response to anti-VEGF therapy in the Comparison of AMD Treatments Trials (CATT).  Letter to the Editor. Ophthalmology 2014; 121:1663-4. Epub 2014 May 9.

Top ∧

CAPT Study Publications

Complications of Age-related Macular Degeneration Prevention Trial Research Group. The Complications of Age-related Macular Degeneration Prevention Trial (CAPT): Rationale, design and methodology. Clinical Trials 2004; 1:91-107.

Complications of Age-related Macular Degeneration Prevention Trial Research Group.  The Complications of Age-related Macular Degeneration Prevention Trial (CAPT): Rationale, design and methodology. Clinical Trials 2004; 1:1-17. [PMID: 16281465]

Complications of Age-related Macular Degeneration Prevention Trial Research Group.  Baseline characteristics, the NEI-VFQ-25, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2004; 111:1307-1316. [PMID: 15234130]

Complications of Age-related Macular Degeneration Prevention Trial Research Group.  Laser Treatment in patients with bilateral large drusen: The Complications of Age-related Macular Degeneration Prevention Trial.  Ophthalmology 2006; 113:1974-1986. [PMID: 17074563]

Maguire MG, Alexander J, Fine SL, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group.  Characteristics of choroidal neovascularization in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT).  Ophthalmology 2008; 115:1468-1473. Epub 2008 May 15. [PMID: 18486222]

Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group.  Risk Factors for choroidal neovascularization and geographic atrophy in the Complications of Age-related Macular Degeneration Prevention Trial.  Ophthalmology 2008; 115:1474-1479.  Epub 2008 May 23.  [PMID: 18502512]

Ying G-S, Maguire M, Liu C, Antoszyk A, Complications of Age-related Macular Degeneration Prevention Trial Research Group.  Night vision symptoms and progression of age-related macular degeneration (AMD) in the Complications of AMD Prevention Trial.  Ophthalmology. 2008; 115:1876-82. Epub 2008 July 30 [PMID: 18672295] [PMCID 2600589]

Ying G-S, Maguire MG, Alexander J, Martin RW, Antoszyk AN, Complications of Age-related Macular Degeneration Prevention Trial Research Group. Description of the AREDS 9-step severity scale applied to participants in CAPT.  Arch Ophthalmol 2009; 127:1147-51. [PMID 19752423]

Maguire MG, Ying G-S, McCannel C, Liu C, Dai Y, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2009; 116:2381-2385. Epub 2009 Oct.22.  [PMID 19850347] [PMCID 2787900] [NIHMS 128128]

Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL; Complications of Age-Related Macular Degeneration Prevention Trial Research Group, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BE, Gotoh N, Yamashiro K, Ferris III F, Fagerness JA, Reynolds R, Farrer LA, Kim IK, Miller JW, Cortón M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, Deangelis MM, Weeks DE, Zack DJ, Chew EY, Heckenlively JR, Yoshimura N, Iyengar SK, Francis PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci 2010; 107:7401-6. Epub 2010 Apr 12.

Ying G-S, Maguire MG, the Complications of Age-related Macular Degeneration Prevention Trial Research Group. Development of a risk score for geographic atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2011; 118:332–338. Epub 2010 Aug 27.

Brader HS, Ying G-S, Martin RE, Maguire, MG, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group.  New grading criteria allow for earlier detection of geographic atrophy in clinical trials.  Invest Ophthalmol Vis Sci 2011; 52:9218–9225. Epub 2011 Oct 28.

Top ∧

Presentations at the Association for Research in Vision and Ophthalmology (ARVO):

Ying, GS. Baseline Characteristics, Vision-related Quality of Life, and Their Associations in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Monday, May 6, 2002. Abstract

K.S. Elsner,E.R. Whittock, R.C. Rees, J. Alexander, B. Madjarov. Grading Drusen from Digital Images. Tuesday, May 7, 2002. Abstract

L.S. Schocket, J.E. Grunwald, T.I. Metelitsina, J.DuPont. Foveolar Choroidal Hemodynamics Three Months after Laser Treatment in Early Age-Related Macular Degeneration. Monday, May 05, 2003. Abstract

M.M. Altaweel, B.A. Blodi, J.N. Ver Hoeve. Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) – Evaluation of Retinal Function in Treated versus Control Eyes with Multifocal Electroretinography. Poster Thursday, May 08, 2003. Abstract

E.R. Whittock, K.S. Elsner, J. Alexander, N.B. Javornik, R. Stoltz. Comparison of Evidence of Low-intensity Laser Burns on Immediate Post Treatment Color Photographs and Post Treatment 12-month Angiograms in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Thursday, May 08, 2003. Abstract

J.E. Grunwald, M. Figueroa, T.I. Metelitsina, L.S. Schocket and J.C. DuPont. Effect of CAPT Laser Treatment on Choroidal Hemodynamics in Age-Related Macular Degeneration (AMD). Poster Tuesday, Apr 27, 2004. Abstract

T.I. Metelitsina, J.E. Grunwald, J.C. DuPont, M.G. Maguire and G.S. Ying. Foveolar Choroidal Blood Flow in Patients with Age–related Macular Degeneration (AMD) Abstract

R.A. Stoltz, G.S. Ying, J. Alexander and the CAPT Study Group. Fundus Features of Untreated Eyes with Visual Acuity Loss in CAPT. Poster Monday, Apr 26, 2004. Abstract

J.A. Sbarbaro, M.G. Maguire and CAPT Study GroupAnnual Changes in Refractive Error Over 3 Years Among Eyes with Early AMD. Poster Tuesday, Apr 27, 2004 Abstract

J. Alexander, K.S. Elsner, N.B. Javornik, E.R. Whittock, M. Brightwell–Arnold, J.L. Duncan, R.A. Stoltz, S.L. Fine and the CAPT Study Group. Characteristics of Exudation in Patients with Bilateral Large Drusen. Poster Tuesday, Apr 27, 2004. Abstract

GS. Ying, C. Liu, M.G. Maguire and the CAPT Research Group. Night-Vision Symptoms as a Risk Factor for Vision Loss and Choroidal Neovascularization (CNV) in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Poster 2005. Abstract

C. Liu, M. Maguire, G.-S. Ying, and CAPT Research Group.  Refractive Error in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): Risk of Late AMD and 5-Year Changes
Invest. Ophthalmol. Vis. Sci. 2007 48: Abstract

GS Ying, MG Maguire, J Alexander, RW Martin, AN Antoszyk, The CAPT Research Group.  The AREDS 9-Step AMD Severity  Scale Applied to Participants in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT): Baseline Classification, Risk of Advanced AMD, and Longitudinal Path Analysis.  Poster April 28, 2008.  Abstract

Nemani D, Wilson CM, Karp KA, Ying G-S, Maguire M, Prince JB, Ng J, Fielder AR, Mills MM, Quinn GE. Semi-automated digital image analysis for eyes with and without retinopathy of prematurity (ROP).  Invest Ophthalmol Vis Sci 2008 49: ARVO E-Abstract 1384.

Maguire MG, Ying G-S.  Evaluation of Incident Advanced Age-Related Macular Degeneration and of Progression on the AREDS 9-Step Severity Scale as Surrogate Outcome Measures in Clinical Trials.  Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 263.

Bisker E, Chang S, Conger A, Hiermath G, Dai Y, Ying G-S, Maguire M, Frohman E, Clalbresi P, Balcer L. Clinical and Ocular Imaging Characteristics of Eyes With Visual Loss Over Time in Multiple Sclerosis.  Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 927.

Ying G-S, Maguire MG, The CAPT Research Group.  Development of a Risk Score for Geographic Atrophy (GA) in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).  Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 1662.

Smolen H, Ying G-S, Martin ER, Maguire MG, The CAPT Research Group. Characteristics of Early Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).  Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 3915.

Stone RA, Ying G-S, Pearson DJ, Bansal M, Puri M, Miller E, Alexander J, Piltz J, Nyberg W, Maguire MG, Eledath J, Sawhney H. Utility of Digital Stereo Images for Optic Disc Evaluation, Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 5808.

Top ∧

Retinopathy in the Chronic Renal Insufficiency Cohort (RCRIC) Abstract

JE Grunwald, J Alexander, R Whittock, K McWilliams, CA Gadegbeku, JP Lash, JC Lo, R Townsend, CRIC Study Group.  Prevalence of Fundus Pathology in the Chronic Renal Insufficiency Cohort.  ARVO April 28, 2008.  Abstract

 

CNVPT Publications

Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen: short term effects seen in a pilot randomized clinical trial. Ophthalmology 1998; 105:11-23. Abstract

Choroidal Neovascularization Prevention Trial Research Group. Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. Ophthalmology. 1998; 105:1364-1372. Abstract

Ho AC. Maguire MG. Yoken J. Lee MS. Shin DS. Javornik NB. Fine SL. Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 1999; 106:1367-73; discussion 1374. Abstract

Kaiser RS. Berger JW. Maguire MG. Ho AC. Javornik NB. Choroidal Neovascularization Prevention Trial Study Group. Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Archives of Ophthalmology 2001; 119:826-32. Abstract

Prenner JL, Rosenblatt BJ, Tolentino MJ, Ying GS, Javornik NB, Maguire MG, Ho AC; CNVPT Research Group. Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT.   Retina 2003; 23:307-14. Abstract

Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology 2003; 110:971-8.  Article

Top ∧

Vision in Preschoolers (VIP) Study Publications

Vision In Preschoolers (VIP) Study Group. Visual acuity results in school-aged children and adults: Lea symbols chart versus Bailey-Lovie chart. Optometry & Vision Science. 2003; 80:650-4.  Article

Vision In Preschoolers (VIP) Study Group. Threshold visual acuity testing of preschool children using the crowded HOTV acuity test and the Lea symbols acuity test. J AAPOS. 2003; 7:396-9.  Abstract

Schmidt PP, Maguire MG, Moore B, Cyert L for the Vision In Preschoolers Study Group. Testability of preschoolers on stereotests used to screen vision disorders. Optometry & Vision Science. 2003; 80:753-757.  Article

Vision in Preschoolers (VIP) Study Group. Comparison of Preschool Vision Screening Tests as Administered by Licensed Eye Care Professionals in the Vision In Preschoolers (VIP) Study. Ophthalmology 2004; 111:637-650.  Article

The Vision in Preschoolers (VIP) Study Group. Preschool Visual Acuity Screening with HOTV and Lea Symbols:  Testability and Between Test Agreement Optometry & Vision Science 2004; 81:678-683. Article

The Vision in Preschoolers (VIP) Study Group. The Electronic Visual Acuity Tester:  Testability in Preschool Children. Optometry & Vision Science 2004; 81:238-244.  Article

Vision in Preschoolers (VIP) Study Group. Sensitivity of screening tests for detecting VIP-targeted vision disorders when specificity is 94%. Optometry and Vision Science 2005; 82:432-438.  Article

The Vision in Preschoolers (VIP) Study Group. Preschool Vision Screening Tests Administered by Nurse Screeners Compared with Lay Screeners in the Vision in Preschoolers Study Investigational Ophthalmology and Visual Science 2005; 46:2639-2648.  Article

Cheatham L, Duson A, Qualley P, Biddle M, Haas B, Peskin E, Cyert L, Dobson V, Quinn GE, Schmidt PP. Implementation of a Preschool Vision Screening Program in a Mobile Setting. NHSA Dialog: A Research-to-Practice Journal for the Early Intervention Field 2005; 8:16-24.

Vision in Preschoolers (VIP) Study Group.  Random Dot E Stereotest: Testability and Reliability in 3 to 5 Year-Old Children.  JAAPOS 2006; 10:507-514. PMC 1884952

Vision in Preschoolers (VIP) Study Group.  Children unable to perform screening tests in Vision In Preschoolers Study: proportion with ocular conditions and impact on measures of test accuracy.  Invest Ophthalmol Vis Sci 2007; 48:83-87.

Vision in Preschoolers (VIP) Study Group.  Impact of confidence number on the screening accuracy of the Retinomax autorefractor.  Optom Vis Sci 2007; 84:181-185.

Vision in Preschoolers (VIP) Study Group.  Does Assessing Eye Alignment along with Refractive Error or Visual Acuity Increase Sensitivity for Detecting Strabismus in Preschool Vision Screening?  Invest Ophthalmol Vis Sci; 2007; 48:3115-3125.  PMC 2140241

Kulp MT, Vision in Preschoolers Study Group.  Findings from the Vision in Preschoolers (VIP) Study.  Optom Vis Sci 2009;86:619-23. Erratum in: Optom Vis Sci 2009; 86:1026. [PMID: 19417714] PMC 2806243

Vision in Preschoolers (VIP) Study Group (Writing team member; Director of the Coordinating Center). Impact of confidence number on the screening accuracy of the SureSight vision screener.  Optom Vis Sci 2010; 87:96-103. Epub 2010 Jan 7.  NIHMS 181130 PMC 2842082.

Vision in Preschoolers (VIP) Study Group (Writing team member; Director of the Coordinating Center).  Age-specific comparisons of the performance of Lea symbols and HOTV optotypes in preschool vision screening. Optom Vis Sci (in press)

Vision in Preschoolers Study Group.  Effect of Age Using Lea Symbols or HOTV for Preschool Vision Screening. Optom Vis Sci 2010; 87:87-95.  NIHMS 181128  PMC 2895492.

Vision In Preschoolers (VIP) Study Group. Comparison of the Retinomax and Palm-AR auto-refractors: A pilot study. Optom Vis Sci. 2011; 88:830-6. Epub 2011 Apr 21. PMC 3125429

Ying G-S, Maguire M, Quinn G, Kulp M, Cyert L. ROC Analysis of the accuracy of noncycloplegic retinoscopy, Retinomax autorefractor and SureSight vision screener for preschool vision screening.  Invest Ophthalmol Vis Sci 28 2011;52:9658–64. Epub 2011 Nov 28. PMC3341123.

Ying G-S, Huang J, Maguire MG, Quinn G, Kulp MT, Ciner E, Cyert L, Orel-Bixler D, and Vision In Preschoolers (VIP) Study Group. Association of anisometropia with unilateral amblyopia, interocular acuitydifference and stereoacuity in preschoolers. Ophthalmology 2013;120:495-503.  PMC3582825.

Huang J, Maguire M, Ciner E, Kulp M, Quinn G, Orel-Bixler D, Cyert L, Moore B, Ying G-S.  Inter-tester agreement in refractive error measurements between lay and nurse screener in administering Retinomax autorefractor and SureSight vision screener. Optom Vis Sci 2013; 90:1128-1137. PMC3894690.

Pascual M, Huang J, Maguire MG, Kulp MT, Quinn GE, Ciner E, Cyert LA, Orel-Bixler D, Moore B, Ying G-S, , and the Vision in Preschoolers (VIP) Study Group.  Risk factors for amblyopia in the Vision in Preschoolers (VIP) Study. Ophthalmology 2014;121: 622-629. Epub 2013 Oct 18.  PMC3943664.

Ying G-S, Maguire M, Ciner E, Cyert L, Kulp MT, Quinn GE, Orel-Bixler D, Moore B, and the Vision in Preschoolers (VIP) Study Group.  Prevalence of vision disorders by racial and ethnic group among children participating in Head Start. Ophthalmology 2014; 121:630-6. Epub 2013 Oct 31.

Ciner EB, Ying G-S, Kulp MT, Maguire MG, Quinn GE, Cyert LA, Orel-Bixler D, Moore B, Huang J.  Stereoacuity of preschool children with and without vision disorders. Optom Vis Sci 2014 ;91:351-8.

Kulp MT, Ying G-S, Huang J, Maguire M, Quinn GE, Ciner EB, Cyert LA, Orel-Bixler DA, Moore BD. Associations of hyperopia with amblyopia, strabismus, other refractive errors and stereoacuity.  Optom Vis Sci. 2014; 91:383-9. Epub 2014 Jan 30.

Kulp MT, Ying G-S, Huang J, Maguire M, Quinn GE, Ciner EB, Cyert LA, Orel-Bixler DA, Moore BD.  Accuracy of noncycloplegic retinoscopy, Retinomax autorefractor and SureSight Vision Screener for detecting significant refractive errors. Invest Ophthalmol Vis Sci 2014 6; 55:1378-85. PMC3945898.

 

VIP Study Group (Earlier Publications)

Ciner EB, Schmidt PP, Orel-Bixler D, Dobson V, Maguire M, Cyert L, Moore B, Schultz J. Vision screening of preschool children: Evaluating the past, looking toward the future. Optom Vision Sci 1998; 75:571-84. Abstract

Ciner EB, Dobson V, Schmidt PP, Allen D, Cyert L, Maguire M, Moore B, Orel-Bixler D, Schultz J. A survey of vision screening policy of preschool children in the United States. Surv Ophthalmol 1999; 43;445-57.  Article

Top ∧

Age-related Macular Degeneration and Radiotherapy Trial (AMDRT) Publications

The AMDRT Research Group. The Age-Related Macular Degeneration Radiotherapy Trial (AMDRT): One Year Results from a Pilot Study American Journal of Ophthalmology, 2004; 138:818-828.  Article

Marcus, DM. Peskin, E. Alexander, JA. Weissgold, G. Maguire, MG Maguire, AM. Fine, SL. The Age-Related Macular Degeneration Radiotherapy Trial(AMDRT): 1 Year Results Investigative Ophthalmology and Visual Science, 2003; 44: E-Abstract 3158. Abstract

Maguire MG. Maguire, AM. Fine SL. and the AMDRT Study Group.  The Age-related Macular Degeneration Radiotherapy Trial (AMDRT): Baseline Characteristics Investigative Ophthalmology and Visual Science, 2002; 43: E-Abstract 1207 Abstract

 

Age-Related Macular Degeneration And Thalidomide Study (AMDATS) Publications

SL Fine, MG Maguire, AM Maguire, RJ D’Amato, LJ Singerman, the AMDATS Research Group. Results of the Age-Related Macular Degeneration and Thalidomide Study (AMDATS) Investigative Ophthalmology and Visual Science March 2001, Vol 42, Abstract 1255.

 

Biostatistics Module Publications - Since September 2000

Volpe NJ, Plotkin ES, Maguire MG, Hariprasad R, Galetta SL. Portable pupillography of the swinging flashlight test to detect afferent pupillary defects. Ophthalmology 2000; 107:1913-1921.  Article

Balcer LJ, Baier  ML, Kunkle AM, Rudick  RA, Weinstock-Guttman B, Simonian N, Galetta SL, Cutter GR, Maguire MGSelf-Reported Visual Dysfunction in Multiple Sclerosis:  Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25).  Multiple Sclerosis 2000; 6:382-385.  Article

Kaiser RS, Berger JW, Maguire MG, Shin DS, Ho AC, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Research Group. Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Archives of Ophthalmology 2001; 119:826-832.  Abstract

Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG.  Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Investigational Ophthalmology & Visual Science2001; 42:1873-1881.  Article

Stone RA, Lin T, Sugimoto R, Capehart C, Maguire MG, Schmidt GF. Corneal surface area: an index of anterior segment growth.  Ophthal Physiol Opt  2001; 21:286-295.  Article

Aleman TS, LaVail MM, Montemayor R, Ying GS, Maguire MG, Laties AM, Jacobson SG, Cideciyan AV.  Augmented rod bipolar cell function in partial receptor loss:  an ERG study in P23H rhodopsin transgenic and aging normal rats.  Vision Research 2001; 2779-2797.  Article

Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG. Visual loss in children with neurofibromatosis type-1 and optic pathway gliomas:  Relation to tumor location by MR imaging.  American Journal of Ophthalmology 2001; 131:442-445.  Article

Loman J, Quinn GE, Kamoun L, Ying GS, Maguire MG, Hudesman D, Stone RA.  Darkness and near work: Myopia and its progression in third-year law students. Ophthalmology 2002; 1032-1038.  Article

Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C.  Early age-related maculopathy and self-reported visual difficulty in daily life.  Ophthalmology 2002: 109:1235-1242.  Article

Ma SL, Shea JA, Galetta SL, Jacobs DA, Markowitz CE, Maguire MG, Balcer LJ.  Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire.  American Journal of Ophthalmology 2002; 686-692.  Abstract

Duncan JL, Aleman TS, Gardner LM, De Castro E, Marks DA, Emmons JM, Bieber ML, Steinberg JD, Bennett J, Stone EM, MacDonald IM, Cidediyan AV, Maguire MG, Jacobson SG.  Macular pigment and lutein supplementation in choroideremia.  Experimental Eye Research 2002; 74:371-381.  Article

Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Archives of Ophthalmology 2002; 120:1435-1442.  Abstract

Hahn P, Lindsten T, Ying GS, Bennett J, Milam AH, Thompson CB, Dunaief JL. Proapoptotic Bcl-2 family members, Bax and Bak, are essential for developmental photoreceptor apoptosis. Investigational Ophthalmology & Visual Science  2003; 44:3598-3605.  Article

Lee MS, Balcer LJ, Volpe NJ, Liu GT, Ying GS, Galetta SL. Laser pointer visual field screening. Neuroophthalmology 2003; 23:260-263.  Abstract

Quinn GE, Francis EL, Nipper KS, Flitcroft DI, Ying GS, Rees R, Schmid G, Maguire MG, Stone RA. Highly precise eye length measurements in children ages 3-12 years. Archives of Ophthalmology2003; 121:985-990. Abstract

Prenner JL, Rosenblatt BJ, Tolentino MJ, Ying GS, Javornik NB, Maguire MG, Ho AC, the CNVPT Research Group. Risk factors for choroidal neovascularization and vision loss in the Fellow Eye Study of CNVPT. Retina 2003; 23:307-314.  Abstract

Javitt JC, Zhou, Z, Maguire MG, Fine SL, Willke RJ.  Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 2003; 110:1534-1539.  Article

Vannas AE, Ying GS, Stone RA, Maguire MG, Jormanainen V, Tervo T. Myopia and natural lighting extremes: risk factors in Finnish army recruits. Acta Ophthalmology Scandinavian 2003; 81:588-595.  Article

Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi L, Pfohl DC, Mills M, Bowen J, Ford C, Heidenreich FR, Jacobs DA, Markowitz CE, Stuart WH, Ying GS, Galetta SL, Maguire MG, Cutter CR. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology 2003; 61:1367-1373.  Article

Stone RA, Quinn GE, Francis EL, Ying GS, Flitcroft DI, Parekh P, Brown J, Orlow J, Schmid G. Diurnal axial length fluctuations in human eyes. Investigational Ophthalmology & Visual Science  2004; 45:63-70.  Article

Tolentino MJ, Brucker AJ, Fosnot J, Ying GS, Wu IH, Malik G, Wan S, Reich SJ. Intravitreal injection of VEGF siRNA inhibits growth and leakage in a non-human primate laser induced model of CNV. Retina 2004; 24:132-138.  Abstract

Ibarra MS, Hsu J, Mirza N, Wu I-H, Ying GS,  Mainster MA, Tolentino MJ. Retinal temperature increase during transpupillary thermotherapy: effects of pigmentation, subretinal blood, and choroidal blood flow. Investigational Ophthalmology & Visual Science 2004; 45:3678-3682.  Article

Hahn P, Lindsten T, Lyubarsky A, Ying GS, Pugh EN, Thompson CB, Dunaief JL. Deficiency of Bax and Bak protects photoreceptors from light damage in vivo.   Cell Death and Differentiation 2004; 11:1192-1197.  Article

Metelisina TI, Grunwald JE, Dupont JC, Ying GS.  Effects of Niacin on the choroidal circulation of patients with Age-related Macular Degeneration (AMD). BritishJournal of Ophthalmology 2004; 88:1568-1572.  Article

Top ∧

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS.  Effect of Viagra on the ocular circulation of AMD patients. Experimental Eye Research 2005, 81:159-64.  Article

Roman AJ, Schwartz SB, Alman TS, Cideciyan AV, Chico JD, Windsor E, Gardner LM, Ying GS, Smilko EE, Maguire MG, Jacobson SG. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Experimental Eye Research 2005; 80:259-272.  Article

Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Investigational Ophthalmology & Visual Science 2005; 46:1033-1038.  Article

Heidary G, Ying GS, Maguire MG, Young TL. The association of astigmatism and spherical refractive error in a high myopia cohort. Optometry & Visual Science 2005, 82:244-247.  Abstract

Kupersmith MJ, Ying GS. Ocular motor dysfunction in ocular myasthenia gravis: effects of treat. British Journal of Ophthalmology. 2005 Oct;89(10):1330-4.  Article

Pineles S, Volpe NJ, Miller-Ellis E, Galetta SL, Sankar PS, Shindler KS, Maguire MG.  Automated combined kinetic and static perimetry:  An alternative to standard perimetry in neuro-ophthalmic and glaucoma patients.  Archives of Ophthalmology 2006; 124:363-369.  Article

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS. Effect of systemic hypertension on foveolar choroidal blood flow in age rated macular degeneration (AMD). British Journal of Ophthalmology 2006; 90:342-346.  Article.

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Liu CC.  Effect of Viagra on the retinal vein diameter in AMD patients.  Experimental Eye Research 2006; 83:128-132.  Article

Wilson LB, Quinn GE, Ying GS, Francis EL, Schmid G, Lam A, Orlow J, Stone RA. The relation of axial length and intraocular pressure fluctuations in human eyes. Invest Ophthalmol Vis Sci 2006; 47:1778-84.  Article

Komaromy AM, Garg CD, Ying GS, Liu CC.  The effect of head position on intraocular pressure in horses. American Journal of Veterinary Research 2006; 67:1232-5.  Article

Stone RA, Wilson LB, Ying GS, Liu CC, Criss JS, Orlow J, Lindstrom JM, Quinn GE. Associations between Childhood Myopia and Parental Smoking. Invest Ophthalmol Vis Sci 2006; 47:4277-87.  Article

Tania TY, Mills MD, Beck AD, Joos KM, Ying GS, Liu CC, Piltz-Seymour JR. Central Corneal Thickness and Corneal Diameter in Patients with Childhood Glaucoma. Journal of Glaucoma 2006; 15:524-8.  Abstract

Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ.  Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006;142:1026-35.  Article

Fisher, JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, WInslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ.  Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324-32.  Article

Hahn P, Ying GS, Beard J, Dunaief JL. Iron levels in human retina: sex difference and increase with age. Neuroreport 2006; 17:1803-6.  Article

Rabinowitz MP, Grunwald JE, Karp KA, Quinn GE, Ying GS, Mills MD.  Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age. Archives of Ophthalmology 2007;125:1495-500.  Article

Orlin A, Mills MD, Ying GS, Liu CC.  A Comparison of Hang-Back with Conventional Recession Surgery for Exotropia.  J AAPOS 2007; 11:597-600.  Abstract

Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, Biousse V, Lee AG, Wall M, Kardon R, Acierno MD, Corbett JJ, Maguire MG, Balcer LJ.  Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007; 143:635-41.  Article

Metelitsina TI, Grunwald JE, Dupoint JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in Age-related Macular Degeneration.  Invest Ophthalmol Vis Sci  2008; 49:358-63.  Article

Greller AL, Hoffman AB, Liu C, Ying GS, Vudathala D, Acland GM, Komáromy AM. Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs. Am J Vet Res 2008; 69:273-8.  Article

Ranchod TM, Guercio JR, Ying GS, Brucker AJ, Stoltz RA. Effect of aspirin therapy on photodynamic therapy with verteporfin for choroidal neovascularization. Retina 2008; 28:711-6.  Abstract

Skalet AH, Quinn GE, Ying GS, Gordillo L, Dodobara L, Cocker K, Fielder AR, Ells AL, Mills MD, Wilson C. Gilbert C.  Telemedicine screening for Retinopathy of Prematurity (ROP) in developing countries using digital retinal images: A feasibility project.  J AAPOS 2008; 12:252-8.  Abstract

Zaveri M, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM.  Retinal Imaging by Laser Polarimetry and Optical Coherence Tomography Evidence of Axonal Degeneration in Multiple Sclerosis. Archives of Neurology 2008; 65:924-8.  Article

Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Serace EM, Rossi S, Lyubarsky A,  Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma J, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J.  Safety and efficacy of gene transfer for Leber’s congential amaurosis.  N Engl J Med 2008; 358;2240-8.  Article

Ying GS, Maguire MG, Liu CC, Antoszyk A, and Complications of Age-related Macular Degeneration Prevention Trial Research Group.  Night vision  and progression of Age-related Macular Degeneration (AMD) in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology 2008; 115:1876-82.  Article

Jefferys JL, Alexander J, Hiner CJ, Javornik NB, Smith RE, Bressler NM, Hawkins BS, Maguire MG.  Reproducibility of gradings of retinal photographs in eyes with subfoveal choroidal neovascularization and age-related macular degeneration in the Macular Photocoagulation Study. Ophthalmic Epidemiology 2008; 15:191-201. [PMID: 18569815].

Maguire MG, Alexander J, Fine SL, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Characteristics of choroidal neovascularization in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT).  Ophthalmology 2008;115:1468–1473 Epub 2008 May 15. [PMID: 18486222]

Umscheid CA, Maguire MG, Pines JM, Everett WW, Baren JM, Townsend RR, Mines D, Szyld D, Gross, R.  Untreated hypertension and the emergency department: a chance to intervene?  Acad Emerg Med 2008; 15:529-36. [PMID: 18616438]

Top ∧

Brown JS, Flitcroft DI, Ying GS, Francis EL, Quinn GE, Stone RA.  In Vivo human choroidal thickness measurements: Evidence of diurnal fluctuations. IOVS 2009; 50:5-12.  Article

Lukinova N, Iacovelli J, Dentchev T, Wolkow N, Hunter A, Amado D, Ying GS, Sparrow J, Dunaief JL.  Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. IOVS 2009; 50:1440-7.  Article

Friedman DS, Okeke CO, Jampel HD, Plyler RJ, Ying GS, Jiang YZ, Quigley HA. Risk factors of poor adherence with eyedrops in electronically monitored glaucoma patients. Ophthalmology 2009; 116:1097-1105.  Article

Okeke CO, Quigley HA, MD, Jampel HD, Plyler RJ, Ying GS, Friedman DS. Adherence with Topical Glaucoma Medication Monitored Electronically: the Travatan Dosing Aid (TDA) Study. Ophthalmology 2009; 116:191-9.  Article

Ying GS, Maguire MG, Alexander J, Martin R, Antoszyk A. Description of the AREDS 9-step severity scale applied to participants in CAPT. Archives of Ophthalmology 2009; 127:1147-51.  Article

Maguire MG, Ying GS, McCannel C, Liu CC. Dai Y. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2009; 116:2381-5.  Article

Grunwald L, Mills MD, Johnson K, Karp KA, Quinn GQ, Ying GS, Grunwald JE. Does change in retinal vessel diameter over time predict severe retinopathy of prematurity? Am J of Ophthalmol 2009; 147:1086-1091.

Hahn P, Song Y, Ying GS, He X, Beard J, Dunaief JL. Age-dependent and gender-specific changes in mouse tissue iron by strain. Experimental Gerontology 2009; 44:594-600.  Article

Iacovelli J, Mlodnicka AE, Veldman P, Ying GS, Dunaief JL, Schumacher A. Brain and retinal ferroportin 1 dysregulation in polycythaemia mice. Brain Res. 2009; 1289:85-95.  Article

Shah DN, Wilson C, Ying GS, Karp K, Fielder A, Ng J, Mills MD, Quinn GE. Semiautomated digital image analysis of posterior pole vessels in retinopathy of prematurity. J APPOS 2009; 13:504-6.  Article

Shah DN, Karp K, Ying GS, Mills MD, Quinn GE.  Image analysis of posterior pole vessels identifies type I retinopathy of prematurity. J APPOS 2009; 13:507-8.  Article

Volpe NJ, Dadvand L, Kim SK, Maguire MG, Ying GS, Moster ML, Galetta SL, M. D. Computerized Binocular Pupillography of the Swinging  Flashlight Test Detects Afferent Pupillary Defects. Current Eye Research 2009; 34:606-13.  Article

Maguire AM, High KA, Auriccho A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli J, Ying GS, Rossi S, Marshall KA, Banfi S, Chung D, Morgan JA, Hauck B, Zelanaia O, Zhu X, Raffini L, Coppieters F, Elfride DB, Schindler K, Volpe N, Surace EM, Acerra C, Lyubarsky A, Redmond TM, Stone E, Sun J, , McDonnell JW, Leroy BP, Simonelli F, Bennett J. Phase I gene therapy shows reversal of congenital blindness: Age-dependent effect of treatment. Lancet 2009; 374;1597-605.

Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang YZ, Friedman DS. Interventions Improve Poor Adherence with Once Daily Glaucoma Medications in Electronically Monitored Patients. Ophthalmology: 2009; 116:2286-93.  Article

Simonelli F, Maguire AM, Testa F ,Pierce EA, Mingozzi F, Bennicelli J, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond M, Zhu X, Shindler KS, Ying GS, Ziviello C, Acerra C, Wright JF, DcDonnel JW, High KA, Bennett J, Auricchio A. Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Molecular Therapy 2009 Dec 1. [Epub ahead of print].

Mowry EM, Loguidice MJ, Daniels AB, Jacobs DA, MD; Markowitz CE, Galetta SL, Nano-Schiav ML, Cutter GR, Maguire MG, Balcer LJ.  Vision-related quality of life in multiple sclerosis: correlation with new measures of low- and high-contrast letter acuity. Neurol Neurosurg Psychiatry 2009; 80:767-72. Epub 2009 Feb 23[PMID: 19240050].

Burkholder BM, Osborne B, Loguidice M,  Frohman TC, Conger A, Ratchford JN, Warner C, Markowitz CE, Jacobs DA, Galetta SL, Cutter GR, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM. Macular volume by optical coherence tomography as measure of neuronal loss in multiple sclerosis.  Arch Neurol 2009; 66:1366-72. [PMID: 19901168].

Shah DN, Bisker E, Frohman TC, Salter A, MS, Conger A, Jacobs DA, Markowitz CE, Dai Y, Ying GS, Maguire, MG, Galetta SL, Calabresi PA, Frohman EM, Balcer LJ. Relation of vision to regional retinal nerve fiber layer thinning in multiple sclerosis:  analysis by optical coherence tomography (OCT) and scanning laser polarimetry (GDx). (Submitted)

Stone RA, Ying GS, Pearson DJ, Dansal M, Puri M, Miller E, Alexander J, Piltz J, Nyberg W, Maguire MG, Eledath J, Sawhney H. Utility of digital stereo images for optic disc evaluation. (Submitted)

Top ∧

© The Trustees of the University of Pennsylvania || Site best viewed in a supported browser. || Site Design: PMACS Web Team
Search Contact